BioSpace News Archive

After the regulator rejected avasopasem manganese, its candidate for severe oral mucositis, Galera is implementing a restructuring initiative that involves reducing its headcount by 70%.

Despite being heavily pretreated, patients on J&J’s Talvey saw a 73.6% overall response rate in a Phase II study, winning accelerated approval from the regulator.

The FDA has four decisions on deck this week, including ones for two rare disease treatments from Ipsen and Regeneron.

The company has lowered its 2023 guidance amid leadership changes and antitrust scrutiny. Illumina now expects a 1% increase in revenue, down from its previous 7% to 10% growth forecast.

Amid record sales of its obesity treatment Wegovy, as well as diabetes drugs Ozempic and Rybelsus, Novo is buying Canadian biotech Inversago Pharma to further boost its weight-loss pipeline.

Vera Therapeutics, Inc., a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, reported its business updates and financial results for the second quarter ended June 30, 2023.

Comera Life Sciences Holdings, Inc., a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience, reported financial results for the second quarter ended June 30, 2023, and provided a business update.

IMUNON, Inc. announced financial results for the three and six months ended June 30, 2023.

Daxor Corporation announces a research letter in the Journal of the American College of Cardiology – Heart Failure reporting on the successful results of a pilot 31 patient randomized control trial conducted by the Duke Clinical Research Institute utilizing Daxor’s BVA-100 diagnostic to measure clinician assessment accuracy and the impact of optimizing decongestion therapy for heart failure patients with the diagnostic.

Ocean Biomedical, Inc. shared today an update on its broad range of promising programs in malaria, fibrosis, and multiple cancers.